Pilot Study to Assess Telemonitoring of Gleevec (Imatinib Mesylate) or Tasigna (Niltinib) Therapy

Clinical trial NCT01490775 · TERMINATED

Trial details

NCT number: NCT01490775
Sponsor: Rex Cancer Center, Raleigh, NC
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

Chronic Phase CML

Start date: 2009-04-01
Primary completion: 2015-02-12
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.